Dhruvil J Pandya

Dhruvil J Pandya, MD serves as a Clinical Assistant Professor in the Ken and Ruth Davee Department of Neurology at Northwestern University's Feinberg School of Medicine, specializing in neurocritical care and stroke interventions.

His educational background includes:

• MD from Ross University (2005)
• Internal Medicine Internship at Medical College of Wisconsin (2006)
• Internal Medicine Residency at Medical College of Wisconsin (2010)
• Neurocritical Care Fellowship at Medical College of Wisconsin (2012)
• Neurology Fellowship at Medical College of Wisconsin (2013)

Dr. Pandya's research focuses on acute stroke interventions, neurocritical care protocols, and neurointerventional techniques. His work emphasizes thrombectomy procedures for large-vessel occlusion strokes, aneurysm management, and endovascular tumor treatments. As evidenced by his lead role in the landmark 2024 TESLA randomized clinical trial, he drives innovation in stroke care through rigorous clinical research.

His publication record reveals consistent contributions to neurointerventional standards, with particular expertise in mechanical thrombectomy devices and retreatment strategies for complex cerebrovascular conditions. Current research priorities include optimizing imaging protocols for stroke intervention and improving outcomes in neurocritical care settings.

Dr. Pandya maintains active industry relationships including board service for Wellness Activities and equity positions in Galaxy Therapeutics, Inc., Insera Therapeutics, LLC, and NeuroTechnology Investors (NTI), reflecting his engagement with neurovascular innovation beyond academic medicine.